LGBT Cancer Project

Therapeutic Areas: Oncology | Immunology

Graft-Versus-Host Disease (GVHD) Clinical Trials

A listing of Graft-Versus-Host Disease (GVHD) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Research Center
Duarte California 31010

A Single-Cohort, Phase 2 Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft Versus-Host Disease

Los Angeles California 91403

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Colorado

Colorado Blood Cancer Institute
Denver Colorado 80218

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Illinois

University of Chicago
Chicago Illinois 60637

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Beth Israel Deaconess Medical Center
Boston Massachusetts 2215

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

New York

Ohio

Onclology Hematology in Cincinnati
Cincinnati Ohio 45236

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Tennessee

Sarah Cannon Research Institute, LLC
Nashville Tennessee 375203

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Texas

Texas Transplant Institute
San Antonio Texas 78229

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Austria

Graz 8036

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Vienna A-1090

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Canada

Hamilton Ontario L8V 5C2

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Israel

Haifa 31096

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease

Petaẖ Tiqwa 49100

A clinical trial to evaluate treatments for patients with Graft-versus-host Disease